Emery-Dreifuss muscular dystrophy (EDMD)

Overview

Emery-Dreifuss muscular dystrophy (EDMD) is a group of inherited conditions causing slowly progressive muscle weakness and wasting, joint contractures, and problems with the heart's electrical conduction system. Several different genes can cause it, so how it presents varies: EDMD type 1 (the EMD gene), EDMD type 2 (LMNA/C, previously classed as LGMD1B), and an X-linked form (FHL1).

Symptoms

Onset is usually in childhood or adolescence. Often the very first sign is stiffness — contractures — at the ankles, neck or elbows, which can show up as a tiptoe walk (from tight ankles) or difficulty fully bending or straightening the arms. Contractures themselves aren't usually painful, though they can make sitting or walking uncomfortable, and some people report leg muscle pain.

Most people develop weakness and wasting in the calves, shoulders and arms, and in some the thighs and hips are affected too; progression is generally slow over many years, though walking can become increasingly difficult and some eventually need a wheelchair. Breathing muscles can weaken, particularly as the condition advances, causing poor sleep, fatigue, morning headaches or daytime sleepiness, and a higher risk of chest infections.

Heart problems are usually about 'conduction' — disruption to the electrical signals that coordinate the heartbeat — leading to arrhythmias that can cause breathlessness, tiredness or palpitations. These need close monitoring since they carry a risk of sudden cardiac events even when someone feels fine, and can, in some cases, affect life expectancy — which is exactly why regular cardiology review matters here as much as, if not more than, muscle symptoms.

Inheritance

LMNA/C-related EDMD is autosomal dominant: one changed copy from an affected parent is enough, that parent also has the condition, and there's a 1 in 2 chance of passing it to each child (occasionally the change arises fresh in someone with no family history, and can then be passed on from them). EMD- and FHL1-related EDMD are X-linked recessive: men with a changed copy are affected; women, with two X chromosomes, are usually unaffected carriers who have a 1 in 2 chance of passing the change to each child — a son who inherits it will have EDMD, while a carrier daughter usually has no symptoms, though rarely some mild weakness or heart involvement can occur.

Getting a diagnosis

A GP can refer to a neurologist, who combines a physical exam (contractures alongside relatively preserved muscle strength is a notable early pattern), blood tests (raised creatine kinase points to muscle damage), and genetic testing, sometimes alongside a muscle biopsy or MRI to look at which muscles are affected and how. A genetic blood test identifying a change in one of the known EDMD genes confirms the diagnosis.

Management and outlook

A multidisciplinary team is essential, with a neurologist typically coordinating care and a cardiologist providing regular heart monitoring — heart problems are common here and often symptomless, so appointments (ECG, echocardiogram, Holter monitoring) matter even when nothing feels wrong. Depending on findings, a cardiologist may prescribe heart-protective medication or recommend a pacemaker or implantable defibrillator; severe cases occasionally need a heart transplant.

Breathing should be monitored with FVC testing at appointments and overnight sleep studies as needed, with breathing exercises, cough-assist devices or non-invasive ventilation available if required. Staying active matters for maintaining strength and joint flexibility — a physiotherapist can build a plan around stretching (aiming for 4-6 times a week), strengthening (2-3 times a week) and aerobic exercise (3-4 times a week). Orthotic support can help with foot drop, improving both walking safety and confidence.